Advantages:

1. We believe that any label probe may change the “original” 3D structure and creating the “ARTIFACT” results causing the failure of down-stream drug development.
2. “ Non-label molecular detection” will solve this problem and saving billion dollars during drug R&D venture.
3. Without obstacle of “LABELING” DETECTION TARGET
4. With tiny amount of testing sample and fast detection time.
5. For diagnose at very early stages with novel surrogate biomarkers. Identify responsive patients and individual drug dosage.

Technology: Vinco-1G